补充剂与发生心律失常的风险的关联
Ru Chen1, Duqiu Liu2, Chenxing Yang3
1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The journal of nutrition, health & aging
|May 2, 2025
概括
补充剂可能会增加患心律不整的风险,包括心房动和心律不整. 这一发现表明,在开始补充之前,需要仔细考虑潜在风险.
科学领域:
- 心脏病学 心脏病学
- 临床电生理学 临床电生理学
- 营养科学 营养科学
背景情况:
- 对心脏功能至关重要,但其与心律失常的联系尚未完全理解.
- 习惯性摄入补充剂对发生心律失常风险的影响需要研究.
研究的目的:
- 为了检查定期使用补充剂和心律不整的发生之间的关联.
- 为了确定补充是否会影响特定心律失常的风险,如心房动/动,心室心律失常和肌失常.
主要方法:
- 一项前性队列研究涉及480,972名来自英国生物银行的参与者.
- 习惯性使用补充剂被评估为主要暴露.
- 考克斯比例危险回归模型用于分析心律失常的发病率,平均随访时间为11.69年.
主要成果:
- 补充的使用与总心律失常 (HR 1.11) 的更高风险有关,包括心房动/动 (HR 1.20),心室心律失常 (HR 1.14) 和胸心律失常 (HR 1.18).
- 在补充和诸如估计的膜过率,糖尿病,心血管疾病和心房动多基因风险评分等因素之间发现了显著的相互作用.
结论:
- 习惯性摄入补充剂与发生心律失常的风险增加有关.
- 关于补充的临床决定应该包括对潜在的心律失常风险的彻底评估,特别是在易受影响的个体中.
相关概念视频
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
674
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
674
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.0K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.0K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
385
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
385
Antihypertensive Drugs: Action of Calcium Channel Blockers
393
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
393
Feedback Regulation of Calcium Concentration
3.3K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.3K
Antiepileptic Drugs: Calcium Channel Blockers
232
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
232


